BPH Energy planning new capital raising

BPH Energy (ASX: BPH) hits trading halt ahead of a capital-raising announcement; halt to last until Jan 12, 2026 or until market update, size undisclosed.

CH
Colin Hay
·1 min read
BPH Energy planning new capital raising

BPH Energy ASX BPH capital raising trading halt BPH Energy ASX:BPH, Cortical Dynamics ASX:CDX, Clean Hydrogen Technologies ASX:CHT, Advent Energy ASX-listed, PEP11 gas permit, oil and gas exploration Australia, AI enhanced brain monitoring BARM 2.0, EEG anaesthesia monitoring system, capital raising ASX trading halt, Australian biotech and renewable energy investments

Key points

  • BPH halts trading ahead of capital raise.

  • PEP11 Feb court; Advent stake 35.8%.

  • BPH: Cortical Dynamics 16.4%; CH Technologies 16.2%.

Diversified investment company BPH Energy (ASX: BPH) has requested an ASX trading halt in the lead-up to releasing a material announcement related to the execution of a capital raising.

The securities of the company will now remain in the halt until either the

commencement of normal trading on Monday, 12 January 2026, or the release of an announcement to the market.

The nature, size and purpose of the capital raising was not disclosed.

PEP11 hearing

2026 is looming as a significant year for BPH which has investment interests in Australian gas fields, renewable energy technology and biotechnology.

Major attention is focused on the company’s 35.8% direct interest in oil and gas developer Advent Energy and its operatorship of the PEP11 joint venture off the NSW coast.

The PEP11 permit is considered to have significant potential for a gas discovery to help meet growing energy demand on the east coast of Australia.

The licence is facing a key determination on its future at a court hearing scheduled to be held in mid-February.

Cortical Dynamics

Cortical Dynamics, in which BPH has a 16.4% direct interest – is closing in on the technical completion of its AI enhanced brain and pain monitoring system,

The unique BARM 2.0 solution being developed by Cortical integrates hypnotic depth and pain response monitoring and electroencephalogram (EEG) through one system.

It aims to support clinicians through real-time control over anaesthesia, helping hospitals achieve better patient outcomes—both during and after surgery.

Cortical was invited to showcase BARM 2.0 at a number of major industry and government events during the September 2025 quarter.

The company is also developing a range medical Apps which can be used in association with BARM 2.0 or standalone.

Clean Hydrogen Technologies

Elsewhere, Clean Hydrogen Technologies (CHT) - in which BPH holds a 16.2% direct interest - is progressing plans to build facilities in the USA and India after achieving positive results from pilot plants.

CHT is developing technologies aimed at producing hydrogen fuel with minimal to zero carbon emissions, which can be used to decarbonise areas such as transport, steel, and energy.

Stay Informed

Get the latest ASX small-cap news, exclusive interviews, and market insights delivered to your inbox weekly.

Join 100,000+ investors. Unsubscribe anytime.

More Like This

View All